Alumis ALMS
NASDAQ ALMS
$6.82 +0.01 (+0.15%)
At close: Oct 22, 2026 · 4:00 PM EDT

Alumis (ALMS) Consolidated Net Income (2023 - 2026)

Updated

Alumis (ALMS) recorded Consolidated Net Income of -$142.18 million in Q2 2026, compared with $59.36 million a year earlier.

Analysis

Alumis (ALMS) Consolidated Net Income (2023 - 2026) Analysis & Trends

On a TTM basis, Alumis' Consolidated Net Income came in at -$286.5 million as of Jun 30, 2026; for FY2025, it was -$243.29 million.

  • Across earlier years, Consolidated Net Income came in at -$294.23 million in FY2024 and -$158.17 million in FY2023.
  • The Q2 2026 figure is the lowest quarterly Consolidated Net Income in data going back to Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 210.00 Mn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 3.62 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 2.51 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -10.50 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -237.00 Mn
10 Alumis 856.86 Mn -817.98 Mn - -142.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -142.18 Mn
Dec 31, 2025 -92.93 Mn
Sep 30, 2025 -110.75 Mn
Jun 30, 2025 59.36 Mn
Mar 31, 2025 -101.53 Mn
Dec 31, 2024 -94.76 Mn
Sep 30, 2024 -93.12 Mn
Jun 30, 2024 -56.51 Mn
Mar 31, 2024 -47.59 Mn
Dec 31, 2023 -40.13 Mn
Sep 30, 2023 -43.76 Mn
Jun 30, 2023 -36.71 Mn
API Access

Alumis Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ALMS&period=max&api_key=YOUR_API_KEY